Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in OCUL — Ocular Therapeutix, Inc

CIK 923093 STAMFORD, CT

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,132,550
-$71,231 QoQ
Shares Held
522,663
-14.9% QoQ
Ownership
0.238%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#48
of 257 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Derivatives in OCUL

reported options exposure · as of Jun 30, 2026
CallValue
$1,683,148
CallShares
171,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. OCUL ranks #18 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,132,550 522,663
2026-06-30 $1,683,148 171,400
2026-03-31 $5,203,781 614,378
2026-03-31 $3,616,690 427,000
2026-03-31 $4,362,897 515,100
2025-12-31 $4,610,772 379,800
2025-12-31 $3,600,724 296,600
2025-12-31 $6,006,774 494,792
2025-09-30 $1,892,599 161,899
2025-09-30 $4,293,737 367,300
2025-03-31 $583,819 79,648
2024-03-31 $678,232 74,531
2023-12-31 $618,740 138,731
2023-09-30 $546,884 174,167
2023-06-30 $1,036,349 200,843
2023-03-31 $360,383 68,384
2022-12-31 $279,139 99,338
2022-09-30 $256,366 61,775
2022-06-30 $205,176 51,039
2021-12-31 $285,679 40,987
2021-09-30 $947,120 94,712